Risk Classification Systems for Drug Use During Pregnancy
- 1 January 2000
- journal article
- Published by Springer Nature in Drug Safety
- Vol. 23 (3) , 245-253
- https://doi.org/10.2165/00002018-200023030-00006
Abstract
Background: In several countries, risk classification systems have been set up to summarise the sparse data on drug safety during pregnancy. However, these have resulted in ambiguous statements that aKeywords
This publication has 37 references indexed in Scilit:
- In vitro cytotoxicity and teratogenicity of norethisterone and levonorgestrel released from hollow nylon monofilamentsJournal of Controlled Release, 1998
- Drugs During Pregnancy An Issue of Risk Classification and Information to PrescribersDrug Safety, 1996
- Report of the Teratology Society Public Affairs Committee symposium on FDA classification of drugsTeratology, 1993
- Smoking and statistical overkillThe Lancet, 1992
- The effects of fetal exposure to danazolBJOG: An International Journal of Obstetrics and Gynaecology, 1992
- ETRETINATE AND PREGNANCYThe Lancet, 1989
- EMBRYOPATHY IN INFANT CONCEIVED ONE YEAR AFTER TERMINATION OF MATERNAL ETRETINATEThe Lancet, 1988
- Embryotoxicity of sex steroidal hormone combinations in nonhuman primates: I. Norethisterone acetate + ethinylestradiol and progesterone + estradiol benzoate (Macaca mulatta, Macaca fascicularis, and Papio cynocephalus)Teratology, 1987
- MALFORMATION OF FETUS CONCEIVED 4 MONTHS AFTER TERMINATION OF MATERNAL ETRETINATE TREATMENTThe Lancet, 1985
- Female pseudohermaphroditism associated with danazol exposure in utero. Case reportBJOG: An International Journal of Obstetrics and Gynaecology, 1984